Drugs / cisplantin
last change Jun 2024 re-read 2 minutes ago

cisplantin

Developed for
cervical cancer
Investigated by
Sun Yat-sen University

Trials 1 · a red edge is where a trial was stopped

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04799639 Mar 2021 → Jun 2024 cervical cancer, chemotherapy-induced toxicity Sun Yat-sen University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as cisplantin ClinicalTrials.gov intervention name — accepted as the source's own label NCT04799639
Route Intravenous “cisplantin 70mg/m2,ivdrip” NCT04799639